Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Adam S. Grossman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jerrold B. Grossman - $251K of ADMA open-market activity in the last 12 months
- Steve Elms - $217K of ADMA open-market activity in the last 12 months
- Kaitlin M. Kestenberg-Messina - $158K of ADMA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Adam S. Grossman?
Adam S. Grossman is a corporate insider, tracked as President and CEO of ADMA BIOLOGICS, INC. (ADMA). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Adam S. Grossman last file a Form 4?
The most recent primary Form 4 on record is dated 18 March 2026, one of 14 filings going back to 2024.
Has Adam S. Grossman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 17 open-market sales ($3.86M) across all tracked filings.
Where can I see all of Adam S. Grossman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Adam S. Grossman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
